Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
PLN 40.5
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
Medinice S.A. provides medical solution for cardiology and cardiac surgery. The company support scientists for product commercialization including prototyping, clinical trials and certification, and product sales. Medinice S.A. was founded in 2012 and is based in Warsaw, Poland.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is underpriced on P/E, of fair value
Data is available to registered users only
Buy
Sell